HERSHBERG ROBERT
Reporting owner on Forms 3, 4 and 5, CIK 1274139.
HERSHBERG ROBERT reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-07.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| RXRX · RECURSION PHARMACEUTICALS, INC.CIK 1601830 | director | 1 | 2026-10-07 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| RXRX · RECURSION PHARMACEUTICALS, …Class A Common Stock | 2026-10-06 | M exercised | +25,000 | $2.22 | 187,156 | Form 4 |
| RXRX · RECURSION PHARMACEUTICALS, …Class A Common Stock | 2026-10-06 | S sold | -25,000 | $5 | 162,156 | Form 4 |
| RXRX · RECURSION PHARMACEUTICALS, …Stock Option (Right to Buy), derivative | 2026-10-06 | M exercised | -25,000 | $2.22 | 500,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001601830-26-000119 | RECURSION PHARMACEUTICALS, INC. | 2026-10-07 |